MeSH D004714 - endometrial hyperplasia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Leuprolide, Norethindrone | Lupaneta Pack |  | 2012-12-14 |  |  |
| Accord Healthcare | Progesterone | Progesterone |  | 2023-11-21 |  |  |
| Allergan | Ethinyl estradiol, Norethindrone | Brevicon |  | 1982-01-01 |  |  |
| Progesterone | Crinone |  | 1997-07-31 |  |  | |
| Ethinyl estradiol, Norethindrone | Estrostep Fe |  | 1996-10-09 |  |  | |
| Ethinyl estradiol, Norethindrone | Femcon Fe |  | 2003-11-14 |  |  | |
| Ethinyl estradiol, Norethindrone | Femhrt |  | 1999-10-15 |  |  | |
| Ethinyl estradiol, Norethindrone | Lo Loestrin Fe | 2029-02-02 | 2010-10-21 |  |  | |
| Ethinyl estradiol, Norethindrone | Lo Minastrin Fe | 2029-02-02 | 2013-07-24 |  |  | |
| Ethinyl estradiol, Norethindrone | Minastrin |  | 2013-05-08 |  |  | |
| Ethinyl estradiol, Norethindrone | Norinyl 1+35 |  | 1982-01-01 |  |  | |
| Ethinyl estradiol, Norethindrone | Taytulla |  | 2013-04-19 |  |  | |
| Ethinyl estradiol, Norethindrone | Norethin |  | 1988-04-12 |  |  | |
| Ethinyl estradiol, Norethindrone | Norethindrone Ethinyl Estradiol |  | 1987-01-29 |  |  | |
| Ethinyl estradiol, Norethindrone | Norethindrone Ethinyl Estradiol () |  | 1991-09-24 |  |  | |
| Norethindrone, Mestranol | Norethindrone Mestranol |  | 1988-07-01 |  |  | |
| Norethindrone, Mestranol | Norinyl |  | 1982-01-01 |  |  | |
| Norethindrone, Mestranol | Norinyl 1+50 |  | 1982-01-01 |  |  | |
| Progesterone | Progesterone |  | 1982-01-01 |  |  | |
| Alza | Progesterone | Progestasert |  | 1982-01-01 |  |  |
| Amarin Corporation | Medroxyprogesterone | Amen |  | 1982-01-01 |  |  |
| American Regent | Progesterone | Progesterone |  | 2009-06-22 |  |  |
| Amneal Pharmaceuticals | Estradiol, Norethindrone | Activella |  | 1998-11-18 |  |  |
| Estradiol, Progesterone | Estradiol Progesterone |  | 2022-05-16 |  |  | |
| Norethindrone | Norethindrone |  | 2012-07-30 |  |  | |
| Ethinyl estradiol, Norethindrone | Norethindrone Ethinyl Estradiol Ferrous |  | 2009-09-01 |  |  | |
| Progesterone | Progesterone |  | 2017-09-07 |  |  | |
| Medroxyprogesterone | Medroxyprogesterone |  | 2023-06-07 |  |  | |
| Amphastar Pharmaceuticals | Medroxyprogesterone | Medroxyprogesterone |  | 2017-11-28 |  |  |
| Apotex | Ethinyl estradiol, Norethindrone | Norethindrone Ethinyl Estradiol Ferrous |  | 2018-03-21 |  |  |
| Aurobindo Pharma | Ethinyl estradiol, Norethindrone | Aurovela |  | 2017-06-15 |  |  |
| Ethinyl estradiol, Norethindrone | Cyonanz |  | 2016-10-21 |  |  | |
| Norethindrone | Incassia |  | 2016-09-23 |  |  | |
| Ethinyl estradiol, Norethindrone | Nexesta Fe |  | 2017-02-02 |  |  | |
| Norethindrone | Norethindrone |  | 2016-01-08 |  |  | |
| Ethinyl estradiol, Norethindrone | Nylia |  | 2016-10-21 |  |  | |
| Ethinyl estradiol, Norethindrone | Rhuzdah |  | 2022-10-11 |  |  | |
| Norethindrone | Emzahh |  | 2023-01-06 |  |  | |
| Ethinyl estradiol, Norethindrone | Oshih |  | 2023-12-06 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
84%16/19
Phase 3
52%12/23
Approved: 5Overall Success rate: 44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use